Opioid Addiction Crisis

US healthcare giant Johnson & Johnson on Tuesday announced it had reached a $20.4 million settlement to avoid a much-anticipated trial in Ohio for allegedly fueling the opioid addiction crisis.

The US pharmaceutical industry faces tens of billions of dollars in potential damage payments for fueling the opioid addiction crisis after Oklahoma won a $572 million judgment against drugmaker Johnson & Johnson.

An Oklahoma judge on Monday ordered US health care giant Johnson & Johnson to pay $572 million in damages for its role in fostering the state's opioid addiction crisis.

US drugmaker Johnson & Johnson faces a potential record $17 billion damages payout Monday when an Oklahoma judge rules whether its aggressive promotion of opioid painkillers was responsible for the state's addiction epidemic.

A 76-year-old Indian-origin head of a US pharmaceutical major has become the first top executive of a drugmaker to be convicted of bribing doctors in America to prescribe addictive painkillers, fuelling a national opioid crisis which has claimed the lives of tens of thousands of people over two decades.

The US Justice Department announced charges Wednesday against 60 people, including doctors, nurses and pharmacists alleged to have illegally written hundreds of thousands of prescriptions for opioids that have underpinned the country's addiction crisis.

The first prosecution of a pharmaceutical company chief executive tied to opioid overdoses begins this week, when Insys Therapeutics Inc.'s John Kapoor goes on trial. The fallout may jolt an industry facing steep penalties for its own role in the crisis.

This tiny pill just three millimeters in diameter is likely to worsen the nation's drug crisis, according to critics and the head of the FDA's advisory committee on painkillers.

With no decline in America's drug menace, US President Donald Trump declared the opioid crisis in America as a national health emergency. He says complete denial to drugs is good way to avoid addiction.

US healthcare giant Johnson & Johnson on Tuesday announced it had reached a $20.4 million settlement to avoid a much-anticipated trial in Ohio for allegedly fueling the opioid addiction crisis.

The US pharmaceutical industry faces tens of billions of dollars in potential damage payments for fueling the opioid addiction crisis after Oklahoma won a $572 million judgment against drugmaker Johnson & Johnson.

An Oklahoma judge on Monday ordered US health care giant Johnson & Johnson to pay $572 million in damages for its role in fostering the state's opioid addiction crisis.

US drugmaker Johnson & Johnson faces a potential record $17 billion damages payout Monday when an Oklahoma judge rules whether its aggressive promotion of opioid painkillers was responsible for the state's addiction epidemic.

A 76-year-old Indian-origin head of a US pharmaceutical major has become the first top executive of a drugmaker to be convicted of bribing doctors in America to prescribe addictive painkillers, fuelling a national opioid crisis which has claimed the lives of tens of thousands of people over two decades.

The US Justice Department announced charges Wednesday against 60 people, including doctors, nurses and pharmacists alleged to have illegally written hundreds of thousands of prescriptions for opioids that have underpinned the country's addiction crisis.

The first prosecution of a pharmaceutical company chief executive tied to opioid overdoses begins this week, when Insys Therapeutics Inc.'s John Kapoor goes on trial. The fallout may jolt an industry facing steep penalties for its own role in the crisis.

This tiny pill just three millimeters in diameter is likely to worsen the nation's drug crisis, according to critics and the head of the FDA's advisory committee on painkillers.

With no decline in America's drug menace, US President Donald Trump declared the opioid crisis in America as a national health emergency. He says complete denial to drugs is good way to avoid addiction.